-
Start Preamble
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis Panel; Chimeric Antigen Receptor Approaches to AD/ADRD R61 Review Meeting.
Date: July 9, 2024.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ivan Tadeu Rebustini, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, 7201 Wisconsin Avenue, Gateway Bldg. Room 100, Bethesda, MD 20814, (301) 555-1212, ivan.rebustini@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS)
Start SignatureDated: April 19, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-08826 Filed 4-24-24; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Published:
- 04/25/2024
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2024-08826
- Dates:
- July 9, 2024.
- Pages:
- 31763-31763 (1 pages)
- PDF File:
- 2024-08826.pdf